Working Together to Find a Cure     Print Page | Close Window

Press Release

PLASMATECH BIOPHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statement
Form 8-K for PLASMATECH BIOPHARMACEUTICALS INC

3-Dec-2014

Entry into a Material Definitive Agreement, Financial Statement


Item 1.01. Entry into a Material Definitive Agreement

On December 1, 2014, the Company entered into an Unsecured Grid Note, for up to $250,000 with SCO Capital PArtners LLC. As of December 3, 2014 we have drawn a total of $150,000. The interest rate is 8% per annum and the maturity date is November 30, 2015 unless a financing of at least $5,000,000 occurs, then the note is required to be paid in full on such date, or earlier upon the closing of a financing.

The foregoing description of the unsecured grid note is qualified in its entirety by reference to the available text of the unsecured grid note, a copy of which is filed as Exhibit 10.35 with this Form 8-K and incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

10.35 Unsecured Grid Note $250,000, dated December 1, 2014 by and betwwwn the Company and SCO Capital Partners LLC.